Technical Articles
BCL-XL/CRBN PROTAC Kit
BCL-XL/CRBN PROTAC Kit: A Standardized Tool for Advancing Tumor-Selective Protein Degradation Therapy Development
Proteolysis Targeting Chimeras (PROTAC) is a revolutionary drug development platform that harnesses the cell's own ubiquitin-proteasome system to selectively degrade disease-causing proteins.
View details
- Cancer
- BCL-XL/CRBN PROTAC Kit
- Tumor
- Protein degradation
Study on Novel BCL-XL Degraders Developed Based on BCL-XL/CRBN PROTAC Kits to Enhance BCL-2 Inhibitory Function
Evasion of apoptosis is a hallmark of cancer, often involving an imbalance between pro-apoptotic and anti-apoptotic proteins (such as BCL-2 family proteins).
View details
- Cancer
- BCL-XL/CRBN PROTAC Kit
- Apoptosis evasion
- Anti-apoptotic protein
- 1














